Skip to main content

Agenix Licenses Tyrian Dx Technology to Develop Microarray Device

NEW YORK (GenomeWeb News) – Australian diagnostics and biopharmaceutical firm Agenix announced today it is licensing a rapid point-of-care diagnostic technology from Tyrian Diagnostics for development of a microarray device.

Agenix will use Tyrian's DiagnosticIQ platform for human applications. Bayer CropScience currently licenses the technology for agricultural applications.

Agenix is providing Tyrian A$500,000 (US$517,000) in shares of its stock to be paid in installments through June 2014.

DiagnosticIQ comprises a disposable test device that can be used alone or with the DiagnosticIQ Reader. Agenix plans to develop a microarray device based on the technology, which would allow human health diagnostic tests to be processed on the one system, Agenix said.

The terms of the deal also provide Agenix a patent for Tyrian's antibody-based test for active tuberculosis.

"This acquisition advances our product pipeline and adds to our human health diagnostics business," Agenix Chairman and CEO Nicholas Weston said in a statement. "We now have a platform for human health arrays and microarray technology developers globally, as well as a medical device product for our expanding China business."

Based in Melbourne, Australia, Agenix also has a subsidiary, Agenix Biopharmaceutical, based in Shanghai.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.